Crescent Biopharma CBIO
NASDAQ CBIO
$13.92 +0.27 (+1.98%)
At close: Nov 10, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Other financing activities (as filed) (2024 - 2026)

Updated

Crescent Biopharma (CBIO) posted Other financing activities (as filed) of -$144,000 for Q2 2026, compared with $1.31 million a year earlier.

Analysis

Crescent Biopharma (CBIO) Other financing activities (as filed) (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities (as filed) at Crescent Biopharma was -$7.27 million.

  • Quarterly Other financing activities (as filed) has run from a low of -$6.95 million in Q1 2026 to a high of $1.31 million in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Crescent Biopharma 418.60 Mn -288.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144,000.00
Mar 31, 2026 -6.95 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 -1.49 Mn
Dec 31, 2024 -760,000.00
API Access

Crescent Biopharma Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CBIO&period=max&api_key=YOUR_API_KEY